Global Irritable Bowel Syndrome (IBS) Diagnostics Market Growth (Status and Outlook) 2025-2031
According to this study, the global Irritable Bowel Syndrome (IBS) Diagnostics market size will reach US$ million by 2031.
Irritable bowel syndrome (IBS) is defined as a gastro-intestinal disorder causing discomfort in the stomach, along with diarrhea, and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. IBS might also be associated with a surplus of bacteria in the bowels (bacterial overgrowth). People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. IBS diagnostics is done through medical history, physical exam, and imaging tests. However, IBS is majorly diagnosed by lactose intolerance tests, breath test for bacterial overgrowth, blood test, and stool test. The tests are done based on symptoms such as constipation-predominant, diarrhea-predominant, or mixed. It can also detect by various imaging tests such as CT Scan or X-ray, upper endoscopy, and colonoscopy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Irritable Bowel Syndrome (IBS) Diagnostics Industry Forecast” looks at past sales and reviews total world Irritable Bowel Syndrome (IBS) Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Irritable Bowel Syndrome (IBS) Diagnostics sales for 2025 through 2031. With Irritable Bowel Syndrome (IBS) Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Irritable Bowel Syndrome (IBS) Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Irritable Bowel Syndrome (IBS) Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Irritable Bowel Syndrome (IBS) Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Irritable Bowel Syndrome (IBS) Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Irritable Bowel Syndrome (IBS) Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Irritable Bowel Syndrome (IBS) Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Irritable Bowel Syndrome (IBS) Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Irritable bowel syndrome (IBS) is defined as a gastro-intestinal disorder causing discomfort in the stomach, along with diarrhea, and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. IBS might also be associated with a surplus of bacteria in the bowels (bacterial overgrowth). People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. IBS diagnostics is done through medical history, physical exam, and imaging tests. However, IBS is majorly diagnosed by lactose intolerance tests, breath test for bacterial overgrowth, blood test, and stool test. The tests are done based on symptoms such as constipation-predominant, diarrhea-predominant, or mixed. It can also detect by various imaging tests such as CT Scan or X-ray, upper endoscopy, and colonoscopy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Irritable Bowel Syndrome (IBS) Diagnostics Industry Forecast” looks at past sales and reviews total world Irritable Bowel Syndrome (IBS) Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Irritable Bowel Syndrome (IBS) Diagnostics sales for 2025 through 2031. With Irritable Bowel Syndrome (IBS) Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Irritable Bowel Syndrome (IBS) Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Irritable Bowel Syndrome (IBS) Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Irritable Bowel Syndrome (IBS) Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Irritable Bowel Syndrome (IBS) Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Irritable Bowel Syndrome (IBS) Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Irritable Bowel Syndrome (IBS) Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Irritable Bowel Syndrome (IBS) Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Laboratory Tests
- Imaging Tests
- Hospitals and Clinics
- Diagnostic Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Commonwealth Diagnostics International
- Genova Diagnostics
- Gemelli Biotech
- Prometheus Laboratories
- Inova Diagnostics, Inc.
- Biohit Oyj
- Aerodiagnostics, LLC.
- Metabolic Solutions, Inc.
- Sysmex Corporation
- Buhlmann Laboratories AG
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size (2020-2031)
2.1.2 Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Irritable Bowel Syndrome (IBS) Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Irritable Bowel Syndrome (IBS) Diagnostics Segment by Type
2.2.1 Laboratory Tests
2.2.2 Imaging Tests
2.3 Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type
2.3.1 Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Irritable Bowel Syndrome (IBS) Diagnostics Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Diagnostic Centers
2.4.3 Others
2.5 Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application
2.5.1 Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2020-2025)
3 IRRITABLE BOWEL SYNDROME (IBS) DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Player
3.1.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue by Player (2020-2025)
3.1.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IRRITABLE BOWEL SYNDROME (IBS) DIAGNOSTICS BY REGION
4.1 Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2020-2025)
4.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth (2020-2025)
4.4 APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth (2020-2025)
4.5 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2020-2025)
5.2 Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025)
5.3 Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2020-2025)
6.2 APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025)
6.3 APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2020-2025)
7.2 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025)
7.3 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) DIAGNOSTICS MARKET FORECAST
10.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Region (2026-2031)
10.1.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Region (2026-2031)
10.1.2 Americas Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.1.3 APAC Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.1.4 Europe Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.1.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.2 Americas Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Country (2026-2031)
10.2.1 United States Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.2.2 Canada Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.2.3 Mexico Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.2.4 Brazil Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.3 APAC Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Region (2026-2031)
10.3.1 China Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.3.2 Japan Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.3.3 Korea Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.3.4 Southeast Asia Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.3.5 India Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.3.6 Australia Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.4 Europe Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Country (2026-2031)
10.4.1 Germany Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.4.2 France Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.4.3 UK Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.4.4 Italy Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.4.5 Russia Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Region (2026-2031)
10.5.1 Egypt Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.5.2 South Africa Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.5.3 Israel Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.5.4 Turkey Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.6 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Type (2026-2031)
10.7 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Commonwealth Diagnostics International
11.1.1 Commonwealth Diagnostics International Company Information
11.1.2 Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.1.3 Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Commonwealth Diagnostics International Main Business Overview
11.1.5 Commonwealth Diagnostics International Latest Developments
11.2 Genova Diagnostics
11.2.1 Genova Diagnostics Company Information
11.2.2 Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.2.3 Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Genova Diagnostics Main Business Overview
11.2.5 Genova Diagnostics Latest Developments
11.3 Gemelli Biotech
11.3.1 Gemelli Biotech Company Information
11.3.2 Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.3.3 Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Gemelli Biotech Main Business Overview
11.3.5 Gemelli Biotech Latest Developments
11.4 Prometheus Laboratories
11.4.1 Prometheus Laboratories Company Information
11.4.2 Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.4.3 Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Prometheus Laboratories Main Business Overview
11.4.5 Prometheus Laboratories Latest Developments
11.5 Inova Diagnostics, Inc.
11.5.1 Inova Diagnostics, Inc. Company Information
11.5.2 Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.5.3 Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Inova Diagnostics, Inc. Main Business Overview
11.5.5 Inova Diagnostics, Inc. Latest Developments
11.6 Biohit Oyj
11.6.1 Biohit Oyj Company Information
11.6.2 Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.6.3 Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Biohit Oyj Main Business Overview
11.6.5 Biohit Oyj Latest Developments
11.7 Aerodiagnostics, LLC.
11.7.1 Aerodiagnostics, LLC. Company Information
11.7.2 Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.7.3 Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Aerodiagnostics, LLC. Main Business Overview
11.7.5 Aerodiagnostics, LLC. Latest Developments
11.8 Metabolic Solutions, Inc.
11.8.1 Metabolic Solutions, Inc. Company Information
11.8.2 Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.8.3 Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Metabolic Solutions, Inc. Main Business Overview
11.8.5 Metabolic Solutions, Inc. Latest Developments
11.9 Sysmex Corporation
11.9.1 Sysmex Corporation Company Information
11.9.2 Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.9.3 Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Sysmex Corporation Main Business Overview
11.9.5 Sysmex Corporation Latest Developments
11.10 Buhlmann Laboratories AG
11.10.1 Buhlmann Laboratories AG Company Information
11.10.2 Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.10.3 Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Buhlmann Laboratories AG Main Business Overview
11.10.5 Buhlmann Laboratories AG Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size (2020-2031)
2.1.2 Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Irritable Bowel Syndrome (IBS) Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Irritable Bowel Syndrome (IBS) Diagnostics Segment by Type
2.2.1 Laboratory Tests
2.2.2 Imaging Tests
2.3 Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type
2.3.1 Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Irritable Bowel Syndrome (IBS) Diagnostics Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Diagnostic Centers
2.4.3 Others
2.5 Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application
2.5.1 Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2020-2025)
3 IRRITABLE BOWEL SYNDROME (IBS) DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Player
3.1.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue by Player (2020-2025)
3.1.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IRRITABLE BOWEL SYNDROME (IBS) DIAGNOSTICS BY REGION
4.1 Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2020-2025)
4.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth (2020-2025)
4.4 APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth (2020-2025)
4.5 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2020-2025)
5.2 Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025)
5.3 Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2020-2025)
6.2 APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025)
6.3 APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2020-2025)
7.2 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025)
7.3 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) DIAGNOSTICS MARKET FORECAST
10.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Region (2026-2031)
10.1.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Region (2026-2031)
10.1.2 Americas Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.1.3 APAC Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.1.4 Europe Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.1.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.2 Americas Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Country (2026-2031)
10.2.1 United States Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.2.2 Canada Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.2.3 Mexico Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.2.4 Brazil Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.3 APAC Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Region (2026-2031)
10.3.1 China Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast
10.3.2 Japan Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.3.3 Korea Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.3.4 Southeast Asia Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.3.5 India Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.3.6 Australia Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.4 Europe Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Country (2026-2031)
10.4.1 Germany Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.4.2 France Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.4.3 UK Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.4.4 Italy Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.4.5 Russia Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Region (2026-2031)
10.5.1 Egypt Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.5.2 South Africa Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.5.3 Israel Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.5.4 Turkey Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
10.6 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Type (2026-2031)
10.7 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Irritable Bowel Syndrome (IBS) Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Commonwealth Diagnostics International
11.1.1 Commonwealth Diagnostics International Company Information
11.1.2 Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.1.3 Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Commonwealth Diagnostics International Main Business Overview
11.1.5 Commonwealth Diagnostics International Latest Developments
11.2 Genova Diagnostics
11.2.1 Genova Diagnostics Company Information
11.2.2 Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.2.3 Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Genova Diagnostics Main Business Overview
11.2.5 Genova Diagnostics Latest Developments
11.3 Gemelli Biotech
11.3.1 Gemelli Biotech Company Information
11.3.2 Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.3.3 Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Gemelli Biotech Main Business Overview
11.3.5 Gemelli Biotech Latest Developments
11.4 Prometheus Laboratories
11.4.1 Prometheus Laboratories Company Information
11.4.2 Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.4.3 Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Prometheus Laboratories Main Business Overview
11.4.5 Prometheus Laboratories Latest Developments
11.5 Inova Diagnostics, Inc.
11.5.1 Inova Diagnostics, Inc. Company Information
11.5.2 Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.5.3 Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Inova Diagnostics, Inc. Main Business Overview
11.5.5 Inova Diagnostics, Inc. Latest Developments
11.6 Biohit Oyj
11.6.1 Biohit Oyj Company Information
11.6.2 Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.6.3 Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Biohit Oyj Main Business Overview
11.6.5 Biohit Oyj Latest Developments
11.7 Aerodiagnostics, LLC.
11.7.1 Aerodiagnostics, LLC. Company Information
11.7.2 Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.7.3 Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Aerodiagnostics, LLC. Main Business Overview
11.7.5 Aerodiagnostics, LLC. Latest Developments
11.8 Metabolic Solutions, Inc.
11.8.1 Metabolic Solutions, Inc. Company Information
11.8.2 Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.8.3 Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Metabolic Solutions, Inc. Main Business Overview
11.8.5 Metabolic Solutions, Inc. Latest Developments
11.9 Sysmex Corporation
11.9.1 Sysmex Corporation Company Information
11.9.2 Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.9.3 Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Sysmex Corporation Main Business Overview
11.9.5 Sysmex Corporation Latest Developments
11.10 Buhlmann Laboratories AG
11.10.1 Buhlmann Laboratories AG Company Information
11.10.2 Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
11.10.3 Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Buhlmann Laboratories AG Main Business Overview
11.10.5 Buhlmann Laboratories AG Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Irritable Bowel Syndrome (IBS) Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Laboratory Tests
Table 4. Major Players of Imaging Tests
Table 5. Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2020-2025)
Table 8. Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2020-2025)
Table 11. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Player (2020-2025)
Table 13. Irritable Bowel Syndrome (IBS) Diagnostics Key Players Head office and Products Offered
Table 14. Irritable Bowel Syndrome (IBS) Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Region (2020-2025)
Table 19. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Country (2020-2025)
Table 23. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2020-2025)
Table 25. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2020-2025)
Table 27. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Region (2020-2025)
Table 29. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Country (2020-2025)
Table 33. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Irritable Bowel Syndrome (IBS) Diagnostics
Table 39. Key Market Challenges & Risks of Irritable Bowel Syndrome (IBS) Diagnostics
Table 40. Key Industry Trends of Irritable Bowel Syndrome (IBS) Diagnostics
Table 41. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Commonwealth Diagnostics International Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 46. Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 47. Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Commonwealth Diagnostics International Main Business
Table 49. Commonwealth Diagnostics International Latest Developments
Table 50. Genova Diagnostics Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 51. Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 52. Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Genova Diagnostics Main Business
Table 54. Genova Diagnostics Latest Developments
Table 55. Gemelli Biotech Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 56. Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 57. Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Gemelli Biotech Main Business
Table 59. Gemelli Biotech Latest Developments
Table 60. Prometheus Laboratories Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 61. Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 62. Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Prometheus Laboratories Main Business
Table 64. Prometheus Laboratories Latest Developments
Table 65. Inova Diagnostics, Inc. Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 66. Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 67. Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Inova Diagnostics, Inc. Main Business
Table 69. Inova Diagnostics, Inc. Latest Developments
Table 70. Biohit Oyj Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 71. Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 72. Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Biohit Oyj Main Business
Table 74. Biohit Oyj Latest Developments
Table 75. Aerodiagnostics, LLC. Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 76. Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 77. Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Aerodiagnostics, LLC. Main Business
Table 79. Aerodiagnostics, LLC. Latest Developments
Table 80. Metabolic Solutions, Inc. Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 81. Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 82. Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Metabolic Solutions, Inc. Main Business
Table 84. Metabolic Solutions, Inc. Latest Developments
Table 85. Sysmex Corporation Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 86. Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 87. Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Sysmex Corporation Main Business
Table 89. Sysmex Corporation Latest Developments
Table 90. Buhlmann Laboratories AG Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 91. Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 92. Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Buhlmann Laboratories AG Main Business
Table 94. Buhlmann Laboratories AG Latest Developments
Table 1. Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Irritable Bowel Syndrome (IBS) Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Laboratory Tests
Table 4. Major Players of Imaging Tests
Table 5. Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2020-2025)
Table 8. Irritable Bowel Syndrome (IBS) Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2020-2025)
Table 11. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Player (2020-2025)
Table 13. Irritable Bowel Syndrome (IBS) Diagnostics Key Players Head office and Products Offered
Table 14. Irritable Bowel Syndrome (IBS) Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Region (2020-2025)
Table 19. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Country (2020-2025)
Table 23. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2020-2025)
Table 25. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2020-2025)
Table 27. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Region (2020-2025)
Table 29. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Country (2020-2025)
Table 33. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Irritable Bowel Syndrome (IBS) Diagnostics
Table 39. Key Market Challenges & Risks of Irritable Bowel Syndrome (IBS) Diagnostics
Table 40. Key Industry Trends of Irritable Bowel Syndrome (IBS) Diagnostics
Table 41. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Commonwealth Diagnostics International Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 46. Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 47. Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Commonwealth Diagnostics International Main Business
Table 49. Commonwealth Diagnostics International Latest Developments
Table 50. Genova Diagnostics Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 51. Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 52. Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Genova Diagnostics Main Business
Table 54. Genova Diagnostics Latest Developments
Table 55. Gemelli Biotech Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 56. Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 57. Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Gemelli Biotech Main Business
Table 59. Gemelli Biotech Latest Developments
Table 60. Prometheus Laboratories Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 61. Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 62. Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Prometheus Laboratories Main Business
Table 64. Prometheus Laboratories Latest Developments
Table 65. Inova Diagnostics, Inc. Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 66. Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 67. Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Inova Diagnostics, Inc. Main Business
Table 69. Inova Diagnostics, Inc. Latest Developments
Table 70. Biohit Oyj Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 71. Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 72. Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Biohit Oyj Main Business
Table 74. Biohit Oyj Latest Developments
Table 75. Aerodiagnostics, LLC. Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 76. Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 77. Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Aerodiagnostics, LLC. Main Business
Table 79. Aerodiagnostics, LLC. Latest Developments
Table 80. Metabolic Solutions, Inc. Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 81. Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 82. Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Metabolic Solutions, Inc. Main Business
Table 84. Metabolic Solutions, Inc. Latest Developments
Table 85. Sysmex Corporation Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 86. Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 87. Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Sysmex Corporation Main Business
Table 89. Sysmex Corporation Latest Developments
Table 90. Buhlmann Laboratories AG Details, Company Type, Irritable Bowel Syndrome (IBS) Diagnostics Area Served and Its Competitors
Table 91. Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Product Offered
Table 92. Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Buhlmann Laboratories AG Main Business
Table 94. Buhlmann Laboratories AG Latest Developments
LIST OF FIGURES
Figure 1. Irritable Bowel Syndrome (IBS) Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Irritable Bowel Syndrome (IBS) Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Irritable Bowel Syndrome (IBS) Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. Irritable Bowel Syndrome (IBS) Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type in 2024
Figure 10. Irritable Bowel Syndrome (IBS) Diagnostics in Hospitals and Clinics
Figure 11. Global Irritable Bowel Syndrome (IBS) Diagnostics Market: Hospitals and Clinics (2020-2025) & ($ millions)
Figure 12. Irritable Bowel Syndrome (IBS) Diagnostics in Diagnostic Centers
Figure 13. Global Irritable Bowel Syndrome (IBS) Diagnostics Market: Diagnostic Centers (2020-2025) & ($ millions)
Figure 14. Irritable Bowel Syndrome (IBS) Diagnostics in Others
Figure 15. Global Irritable Bowel Syndrome (IBS) Diagnostics Market: Others (2020-2025) & ($ millions)
Figure 16. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application in 2024
Figure 17. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Player in 2024
Figure 18. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2020-2025 ($ millions)
Figure 20. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2020-2025 ($ millions)
Figure 21. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2020-2025 ($ millions)
Figure 23. Americas Irritable Bowel Syndrome (IBS) Diagnostics Value Market Share by Country in 2024
Figure 24. United States Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Region in 2024
Figure 29. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2020-2025)
Figure 31. China Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Country in 2024
Figure 38. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 54. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 55. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 57. United States Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 58. Canada Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 61. China Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 62. Japan Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 63. Korea Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. India Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. Australia Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. Germany Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. France Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. UK Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. Italy Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. Russia Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Israel Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 76. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 1. Irritable Bowel Syndrome (IBS) Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Irritable Bowel Syndrome (IBS) Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Irritable Bowel Syndrome (IBS) Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. Irritable Bowel Syndrome (IBS) Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type in 2024
Figure 10. Irritable Bowel Syndrome (IBS) Diagnostics in Hospitals and Clinics
Figure 11. Global Irritable Bowel Syndrome (IBS) Diagnostics Market: Hospitals and Clinics (2020-2025) & ($ millions)
Figure 12. Irritable Bowel Syndrome (IBS) Diagnostics in Diagnostic Centers
Figure 13. Global Irritable Bowel Syndrome (IBS) Diagnostics Market: Diagnostic Centers (2020-2025) & ($ millions)
Figure 14. Irritable Bowel Syndrome (IBS) Diagnostics in Others
Figure 15. Global Irritable Bowel Syndrome (IBS) Diagnostics Market: Others (2020-2025) & ($ millions)
Figure 16. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application in 2024
Figure 17. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Player in 2024
Figure 18. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2020-2025 ($ millions)
Figure 20. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2020-2025 ($ millions)
Figure 21. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2020-2025 ($ millions)
Figure 23. Americas Irritable Bowel Syndrome (IBS) Diagnostics Value Market Share by Country in 2024
Figure 24. United States Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Region in 2024
Figure 29. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2020-2025)
Figure 31. China Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Country in 2024
Figure 38. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 54. APAC Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 55. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 57. United States Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 58. Canada Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 61. China Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 62. Japan Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 63. Korea Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. India Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. Australia Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. Germany Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. France Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. UK Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. Italy Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. Russia Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Israel Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
Figure 76. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Irritable Bowel Syndrome (IBS) Diagnostics Market Size 2026-2031 ($ millions)
More Publications
Global Silica Gel Sorbent Tube Market Growth 2023-2029
US$ 3,660.00
March 2023
98 pages
Global Next Generation Nebulizer Market Growth 2024-2030
US$ 3,660.00
December 2024
106 pages
Global Articulated Walker Boot Market Growth 2023-2029
US$ 3,660.00
February 2023
107 pages
Global Diabetic Neuropathy Treatment Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
February 2024
103 pages
